|

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

RECRUITINGSponsored by Yale University
Actively Recruiting
SponsorYale University
Started2024-12-12
Est. completion2028-05
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations2 sites

Summary

The goal of this observational study is to learn how the brain's information processing changes during and following administration of serotonergic psychedelics (psilocybin, N,N-Dimethyltryptamine/DMT, Lystergic Acid Diethylamide/LSD, etc.) for people with and without mental illness receiving serotonergic psychedelics through any clinical trial at Yale University. The main questions it aims to answer are: 1. Do serotonergic psychedelics cause the brain to rely on new information more than previously learned information while under the influence? What about 1 day, 5-14 days, and 4-6 weeks after use? 2. Do serotonergic psychedelics cause long-lasting side-effects in how people perceive (see, hear, feel, etc.) the world and how easily people change their beliefs? 3. How does the brain's electrical activity change after using serotonergic psychedelics? How does the balance between excitation and inhibition change while under their effect? 4. Can changes in how the brain uses information predict who will benefit from a psychedelic and who will have side effects from psychedelics? Researchers will compare with people given placebos to see what changes in brain processing are unique to serotonergic psychedelics. Participants will have the opportunity to do some combination of the following: 1. Online computer assessments consisting of games and questionnaires that probe how participants think. 2. Magnetoencephalography (MEG) or electroencephalography (EEG) with eyes closed and with repeated clicks, images, or sensations delivered. 3. A magnetic resonance imaging (MRI) scan. 4. Semi-structured qualitative interviews about their experience after taking a serotonergic psychedelic recorded via Zoom.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participation in approved clinical protocol at Yale University involving potential administration of serotonergic psychedelics
* Absence of pre-existing psychotic symptoms

Exclusion Criteria:

* Current intoxication based on self-report
* Any neurological, medical or developmental problem that is known to impair cognition significantly based on self-report
* History of seizures based on self-report
* Contraindications for MR scanning including metallic implants of any kind, pacemakers and history of accidents with metal, claustrophobia (specific to those who will participate in MRI)

Conditions13

AddictionAlcohol Use Disorder (AUD)AnxietyDepressionHealthy VolunteerMajor Depressive Disorder (MDD)MigraineOCDObsessive Compulsive Disorder (OCD)Opioid Use Disorder

Locations2 sites

Connecticut Mental Health Center
Hamden, Connecticut, 06517
Maximillian S Greenwald, BA203-441-7213‬maximillian.greenwald@yale.edu
West Haven VA Medical Center
West Haven, Connecticut, 06516
Maximillian S Greenwald, BA425-495-9793maximillian.greenwald@yale.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.